Next-Level PFS and Cartridge Filling: Accelerating Timelines and Market Readiness for OBIs and Autoinjectors
Taking Manufacturing PFS and Cartridges to the Next Level
CDMOs cultivating strong partnerships with drug delivery device companies take manufacturing PFS and cartridges to the next level, particularly for on-body delivery systems and autoinjectors. By engaging early with pharmaceutical companies, CDMOs can help to accelerate timelines and improve market readiness.
In the eBook Powering Patient-Centric Delivery: How Partnerships Are Transforming Fill-Finish Services, GRAM’s Director of Drug Product Manufacturing, Tyler BeVier, along with Contract Pharma, uncovers what it takes to bring PFS and cartridge filling to the next level through transformative, patient-centric partnerships.
Discussion questions and topics include:
- How can collaborations with drug delivery device companies enhance syringe and cartridge filling capabilities, particularly for on-body delivery systems and autoinjectors?
- How early in the development process is it recommended for pharma companies to engage with a CDMO when planning to use a drug delivery device—and why is that early collaboration so critical?
- How will GRAM’s new syringe and cartridge filling facility and expanded capabilities help address the evolving needs of biologics and other complex therapies?
- What are some specific ways GRAM’s team connects their daily work to the patient experience?
- How does GRAM’s location within the “Medical Mile” shape your culture and ability to attract top talent focused on improving human health?
- What trends are you seeing in pharma’s push toward more patient-friendly, at-home administration formats, and how is GRAM positioning itself to support that shift?
- How is GRAM working with delivery device companies and pharma partners to streamline and accelerate time-to-market?
- What is the importance of flexibility—both in equipment and approach—when supporting niche or custom drug delivery formats?
Click here to view the eBook
